Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria

OBJECTIVE: We wanted to compare the efficacy of the new CT response evaluation criteria for predicting the tumor progression-free survival (PFS) with that of RECIST 1.1 in non-small cell lung cancer (NSCLC) patients who were treated with bevacizumab. MATERIALS AND METHODS: Sixteen patients (M:F = 11...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lee, Ho Yun, Lee, Kyung Soo, Hwang, Hye Sun, Lee, Ju Won, Ahn, Myung-Ju, Park, Keunchil, Kim, Tae Sung, Yi, Chin A, Chung, Myung Jin
Format: Artigo
Langue:Inglês
Publié: The Korean Society of Radiology 2010
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974223/
https://ncbi.nlm.nih.gov/pubmed/21076587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3348/kjr.2010.11.6.618
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires